TY - CHAP M1 - Book, Section TI - Ibritumomab Tiuxetan A1 - Ciccone, Charles D. PY - 2016 T2 - Davis's Drug Guide for Rehabilitation Professionals AB - ibritumomab tiuxetan (i-bri-too-mo-mab tye-uks-i-tan)ZevalinClassificationTherapeutic: antineoplasticsPharmacologic: monoclonal antibodies, radioisotopes SN - PB - F. A. Davis Company CY - New York, NY Y2 - 2024/03/29 UR - fadavisat.mhmedical.com/content.aspx?aid=1134172096 ER -